Stage IV rectal cancer is a more advanced form of the disease that has spread beyond the rectum and has spread to other organs such as the lungs, bones, or liver. Certain treatments can still cure some patients and provide them with meaningful palliative effects. There are two main groups of patients with stage IV rectal cancer: those whose cancer has been diagnosed in the early stages and those whose cancer has spread to other parts of the body.
Advanced rectal cancer is usually treated with targeted radiation and chemotherapy. In this case, a highly experienced surgeon can remove the tumors while preserving normal function of surrounding organs. In addition, a multidisciplinary team of doctors may be used in patients who are ineligible for surgery alone. During this treatment, chemotherapy and radiation therapy are combined before and after the operation. This approach kills cancer cells that may have spread to other organs but have not been discovered by the colorectal surgeon.
While there are no specific symptoms of rectal cancer, regular screenings are essential to catching the disease early. A highly sensitive stool test is also available and can detect abnormal cells. If the stool contains any abnormal cells, you should schedule a colonoscopy as soon as possible. In addition to screenings, rectal cancer prevention includes a healthy lifestyle and eliminating risk factors like red meat and smoking. Many cases of rectal cancer are curable, so the good news is that many people can avoid this potentially fatal disease.
Although rectal cancer doesn’t always present any symptoms during its early stages, most people don’t even realize they have it. Symptoms of the disease can include an altered bowel pattern, red blood in the stool, and unexplained weight loss. Other symptoms include a general feeling of fatigue, abdominal pain, and pelvic discomfort. In addition, a change in bowel habits can indicate the onset of rectal cancer. Additionally, a continuous urge to urinate may indicate that the bowel is partially empty.
The five-year survival rate for patients diagnosed with rectal cancer is based on the average number of people still alive five years after the diagnosis. This is based on information that was collected between 2010 and 2016. Treatments may have changed since then, so the five-year survival rate will be lower. Patients who have been diagnosed with rectal cancer may wish to participate in clinical trials. They can enter clinical trials before or during the treatment process.
Survivors of rectal cancer may also wish to consider taking part in support groups. While rectal cancer can be frightening, being informed will empower you. Learning about your body’s response to treatments can help you gain control of your health. If you’re unsure whether a sexually active partner is safe, a support group or online forum may provide support and encouragement. The knowledge you gain will enable you to make the right decisions for your life.
